Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 10Head and Neck Neoplasms 5Brain Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Central Nervous System Neoplasms 4Pancreatic Neoplasms 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Wilms Tumor 2Uterine Cervical Neoplasms 2Sarcoma 2Salivary Gland Neoplasms 2Oligodendroglioma 2Neurotoxicity Syndromes 2Malignant mesenchymal tumor 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Hemangiosarcoma 2Fibrosarcoma 2Breast Neoplasms 2Astrocytoma 2Adenocarcinoma of Lung 2Vulvar Neoplasms 1Urinary Bladder Neoplasms 1Untreated Childhood Medulloblastoma 1Tongue Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1

Interventions

Gemcitabine 3Capecitabine 3Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Ondansetron 1Fluorouracil 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Bile Duct Neoplasms × Radiotherapy, Conformal × Clear all
NCT00789958 2018-04-09

S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct

SWOG Cancer Research Network

Phase 2 Completed
105 enrolled 13 charts
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡